CFAP210
gene geneOn this page
Also known as LOC129881
Summary
CFAP210 (cilia and flagella associated protein 210, HGNC:25064) is a protein-coding gene on chromosome 2q31.1, encoding Cilia- and flagella- associated protein 210 (Q0VFZ6). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Predicted to be involved in flagellated sperm motility. Located in axonemal microtubule.
Source: NCBI Gene 129881 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- Clinical variants (ClinVar): 80 total — 1 pathogenic
- GTEx eGene: eQTL in 40 tissues, sQTL in 2 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.34 (unconstrained)
- MANE Select transcript:
NM_001085447 - Notable: 80 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25064 |
| Approved symbol | CFAP210 |
| Name | cilia and flagella associated protein 210 |
| Location | 2q31.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LOC129881 |
| Ensembl gene | ENSG00000154479 |
| Ensembl biotype | protein_coding |
| Entrez | 129881 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 nonsense_mediated_decay
MANE Select: ENST00000447353
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 4: 1, TSL 5: 1
ENST00000447353, ENST00000419478, ENST00000421028, ENST00001093673, ENST00001127360, ENST00001127716, ENST00001137929
RefSeq mRNA: 1 — MANE Select: NM_001085447
NM_001085447
CCDS: CCDS46445
Canonical transcript exons
ENST00000447353 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001016144 | 169649182 | 169649346 |
| ENSE00001146957 | 169650329 | 169650521 |
| ENSE00001225835 | 169645425 | 169646182 |
| ENSE00001404590 | 169654075 | 169654214 |
| ENSE00001527650 | 169662280 | 169662436 |
| ENSE00001527651 | 169674576 | 169674769 |
| ENSE00001527655 | 169681007 | 169681233 |
| ENSE00001631329 | 169694261 | 169694405 |
| ENSE00003498153 | 169674867 | 169675040 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 96.87.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9814 / max 105.4672, expressed in 990 samples.
Highest expression (Bgee): sperm, bronchial epithelial cell, testis, bronchus, uterine tube.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CFAP210 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 40 tissues and its splicing (sQTL) in 2 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 42 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Thyroid | eqtl | 3.8e-35 | -0.81 | 2:169586241:T:C |
| Testis | sqtl | 3.2e-33 | +1.32 | 2:169662859:C:T |
| Nerve Tibial | eqtl | 1.5e-20 | -0.73 | 2:169720801:C:T |
| Testis | eqtl | 3.4e-19 | -0.37 | 2:169662859:C:T |
| Pituitary | eqtl | 1.5e-18 | -0.95 | 2:169713812:TTTTG:T |
| Brain Cortex | eqtl | 8.9e-13 | -0.83 | 2:169586241:T:C |
| Spleen | eqtl | 4.4e-12 | -0.60 | 2:169660518:T:G |
| Brain Hippocampus | eqtl | 1.1e-10 | -0.57 | 2:169652721:C:T |
| Brain Nucleus accumbens basal ganglia | eqtl | 1.4e-10 | -0.64 | 2:169586241:T:C |
| Brain Caudate basal ganglia | eqtl | 4.5e-10 | -0.46 | 2:169582581:G:C |
| Brain Anterior cingulate cortex BA24 | eqtl | 4.1e-09 | -0.77 | 2:169662859:C:T |
| Artery Aorta | eqtl | 5.3e-09 | -0.49 | 2:169723973:A:G |
| Lung | eqtl | 6.0e-09 | -0.27 | 2:169713812:TTTTG:T |
| Esophagus Muscularis | eqtl | 6.5e-09 | -0.60 | 2:169713812:TTTTG:T |
| Artery Tibial | eqtl | 9.0e-09 | -0.30 | 2:169646989:G:A |
| Brain Frontal Cortex BA9 | eqtl | 3.6e-08 | -0.70 | 2:169645833:A:T |
| Colon Sigmoid | eqtl | 2.1e-07 | -0.65 | 2:169671499:G:A |
| Brain Putamen basal ganglia | eqtl | 3.5e-07 | -0.65 | 2:169671647:T:C |
| Brain Hypothalamus | eqtl | 1.3e-06 | -0.46 | 2:169586241:T:C |
| Ovary | eqtl | 2.2e-06 | -0.69 | 2:169671647:T:C |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 31739 | 2.1781 | 808 |
| 31738 | 1.8033 | 518 |
Top tissues by expression
showing 100 of 246 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 96.87 | gold quality |
| bronchial epithelial cell | CL:0002328 | 95.64 | gold quality |
| left testis | UBERON:0004533 | 94.56 | gold quality |
| bronchus | UBERON:0002185 | 94.18 | gold quality |
| right testis | UBERON:0004534 | 94.09 | gold quality |
| testis | UBERON:0000473 | 92.33 | gold quality |
| right uterine tube | UBERON:0001302 | 90.61 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 89.68 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.55 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.70 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.16 | gold quality |
| oviduct epithelium | UBERON:0004804 | 85.50 | gold quality |
| adult organism | UBERON:0007023 | 78.52 | gold quality |
| fallopian tube | UBERON:0003889 | 78.07 | gold quality |
| secondary oocyte | CL:0000655 | 77.70 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 76.44 | gold quality |
| corpus callosum | UBERON:0002336 | 73.13 | gold quality |
| pancreatic ductal cell | CL:0002079 | 72.66 | silver quality |
| ventricular zone | UBERON:0003053 | 71.50 | gold quality |
| adenohypophysis | UBERON:0002196 | 69.96 | gold quality |
| caput epididymis | UBERON:0004358 | 69.44 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 68.41 | gold quality |
| caudate nucleus | UBERON:0001873 | 67.80 | gold quality |
| pituitary gland | UBERON:0000007 | 67.62 | gold quality |
| hypothalamus | UBERON:0001898 | 67.57 | gold quality |
| amygdala | UBERON:0001876 | 66.09 | gold quality |
| sural nerve | UBERON:0015488 | 65.98 | gold quality |
| right lung | UBERON:0002167 | 65.60 | gold quality |
| nucleus accumbens | UBERON:0001882 | 65.12 | gold quality |
| primary visual cortex | UBERON:0002436 | 62.88 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 62.74 | gold quality |
| thyroid gland | UBERON:0002046 | 62.68 | gold quality |
| putamen | UBERON:0001874 | 62.55 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 62.37 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 61.91 | gold quality |
| Ammon’s horn | UBERON:0001954 | 61.85 | gold quality |
| islet of Langerhans | UBERON:0000006 | 61.59 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 61.55 | gold quality |
| endocervix | UBERON:0000458 | 61.41 | gold quality |
| left uterine tube | UBERON:0001303 | 61.29 | gold quality |
| forebrain | UBERON:0001890 | 61.16 | gold quality |
| cerebellar vermis | UBERON:0004720 | 60.97 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 60.88 | gold quality |
| occipital lobe | UBERON:0002021 | 60.83 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 60.51 | gold quality |
| spinal cord | UBERON:0002240 | 60.21 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 59.55 | gold quality |
| brain | UBERON:0000955 | 59.40 | gold quality |
| lung | UBERON:0002048 | 59.35 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 59.12 | gold quality |
| prefrontal cortex | UBERON:0000451 | 58.80 | gold quality |
| temporal lobe | UBERON:0001871 | 58.58 | gold quality |
| upper lobe of lung | UBERON:0008948 | 58.46 | gold quality |
| pancreas | UBERON:0001264 | 58.39 | gold quality |
| endometrium | UBERON:0001295 | 58.31 | gold quality |
| cortex of kidney | UBERON:0001225 | 58.14 | gold quality |
| cerebral cortex | UBERON:0000956 | 58.13 | gold quality |
| right frontal lobe | UBERON:0002810 | 58.05 | gold quality |
| neocortex | UBERON:0001950 | 57.91 | gold quality |
| body of pancreas | UBERON:0001150 | 57.64 | gold quality |
| metanephros cortex | UBERON:0010533 | 57.19 | gold quality |
| calcaneal tendon | UBERON:0003701 | 56.79 | gold quality |
| ganglionic eminence | UBERON:0004023 | 56.77 | gold quality |
| substantia nigra | UBERON:0002038 | 56.64 | gold quality |
| endothelial cell | CL:0000115 | 56.63 | gold quality |
| gall bladder | UBERON:0002110 | 56.59 | gold quality |
| frontal cortex | UBERON:0001870 | 56.54 | gold quality |
| superficial temporal artery | UBERON:0001614 | 56.49 | gold quality |
| midbrain | UBERON:0001891 | 56.45 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 56.41 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 56.33 | gold quality |
| seminal vesicle | UBERON:0000998 | 56.21 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 55.87 | gold quality |
| saphenous vein | UBERON:0007318 | 55.21 | gold quality |
| metanephros | UBERON:0000081 | 54.85 | gold quality |
| vermiform appendix | UBERON:0001154 | 54.49 | gold quality |
| uterine cervix | UBERON:0000002 | 54.47 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 54.46 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| uterus | UBERON:0000995 | 54.29 | gold quality |
| monocyte | CL:0000576 | 54.28 | gold quality |
| right ovary | UBERON:0002118 | 54.24 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| synovial joint | UBERON:0002217 | 54.17 | gold quality |
| cortical plate | UBERON:0005343 | 53.99 | gold quality |
| ovary | UBERON:0000992 | 53.95 | gold quality |
| caecum | UBERON:0001153 | 53.95 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 53.89 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 53.89 | gold quality |
| tibialis anterior | UBERON:0001385 | 53.82 | silver quality |
| tibia | UBERON:0000979 | 53.81 | gold quality |
| thymus | UBERON:0002370 | 53.76 | gold quality |
| left ovary | UBERON:0002119 | 53.70 | gold quality |
| pericardium | UBERON:0002407 | 53.70 | gold quality |
| globus pallidus | UBERON:0001875 | 53.59 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| urethra | UBERON:0000057 | 53.43 | gold quality |
| kidney | UBERON:0002113 | 53.34 | gold quality |
| medial globus pallidus | UBERON:0002477 | 53.20 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 915.49 |
| E-GEOD-130148 | yes | 12.37 |
| E-ANND-3 | yes | 9.17 |
HPA expression
RNA tissue specificity: Group enriched
showing 60 of 75 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Testis | tissue | 74.9 | high |
| Choroid plexus | tissue | 42.9 | |
| Fallopian tube | tissue | 14.0 | medium |
| Hippocampus | tissue | 12.2 | not detected |
| Nucleus accumbens | tissue | 11.6 | |
| Periaqueductal gray | tissue | 9.8 | |
| Basal ganglia | tissue | 8.0 | not detected |
| Olfactory bulb | tissue | 7.7 | |
| Postcentral gyrus | tissue | 7.3 | |
| Septum | tissue | 7.3 | |
| Hypothalamus | tissue | 6.9 | |
| Amygdala | tissue | 6.5 | |
| Cerebral cortex | tissue | 6.4 | not detected |
| Ventral forebrain | tissue | 6.4 | |
| Retrosplenial and cingulate cortex | tissue | 6.4 | |
| Retrosplenial cortex | tissue | 6.4 | |
| Hippocampal formation | tissue | 6.3 | |
| Occipital cortex | tissue | 6.3 | |
| Retina | tissue | 6.2 | |
| Entorhinal cortex | tissue | 6.2 | |
| Prefrontal cortex | tissue | 6.1 | |
| Putamen | tissue | 6.1 | |
| Cerebellum | tissue | 6.1 | not detected |
| Corpus callosum | tissue | 6.1 | |
| Insular cortex | tissue | 6.1 | |
| Temporal cortex | tissue | 5.8 | |
| Somatosensory cortex | tissue | 5.6 | |
| Locus coeruleus | tissue | 5.5 | |
| Motor cortex | tissue | 5.4 | |
| Midbrain | tissue | 4.8 | |
| Medulla oblongata | tissue | 4.7 | |
| Substantia nigra | tissue | 4.7 | |
| Spinal cord | tissue | 4.6 | |
| Pons | tissue | 4.5 | |
| Thalamus | tissue | 4.0 | |
| Superior colliculi | tissue | 3.8 | |
| Bone marrow | tissue | 3.4 | not detected |
| Thyroid gland | tissue | 3.2 | not detected |
| Pituitary gland | tissue | 2.4 | |
| Lung | tissue | 2.3 | not detected |
| Parathyroid gland | tissue | 1.5 | not detected |
| Pancreas | tissue | 1.3 | not detected |
| Breast | tissue | 1.2 | not detected |
| Endometrium 1 | tissue | 1.1 | not detected |
| Epididymis | tissue | 1.1 | not detected |
| Frontal cortex | tissue | 1.1 | |
| Cervix | tissue | 0.9 | not detected |
| Kidney | tissue | 0.9 | not detected |
| Caudate putamen | tissue | 0.9 | |
| Seminal vesicle | tissue | 0.7 | not detected |
| Appendix | tissue | 0.7 | not detected |
| Ovary | tissue | 0.6 | not detected |
| Smooth muscle | tissue | 0.6 | not detected |
| Duodenum | tissue | 0.6 | not detected |
| Gallbladder | tissue | 0.5 | not detected |
| Stomach 1 | tissue | 0.4 | not detected |
| Rectum | tissue | 0.4 | not detected |
| Liver | tissue | 0.4 | not detected |
| Small intestine | tissue | 0.4 | not detected |
| Prostate | tissue | 0.4 | not detected |
Brain sub-regions (HPA Brain Atlas): detected in 189; highest nTPM — Periaquaductal grey, dorsal (31.5), Periaquaductal grey, lateral (29.1), Nucleus tractus solitarii (27.1), Cervical spinal cord, central gray (20.6), Superior vestibular nucleus (16.5).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting CFAP210 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 32 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-187-5P | 99.74 | 70.26 | 1404 |
| HSA-MIR-6740-3P | 99.48 | 68.49 | 1392 |
| HSA-MIR-4506 | 99.34 | 67.47 | 526 |
| HSA-MIR-16-2-3P | 99.29 | 70.60 | 1954 |
| HSA-MIR-195-3P | 99.29 | 70.61 | 1954 |
| HSA-MIR-223-5P | 99.24 | 68.82 | 1206 |
| HSA-MIR-491-5P | 99.13 | 65.98 | 1468 |
| HSA-MIR-140-3P | 99.04 | 67.69 | 1324 |
| HSA-MIR-181A-2-3P | 98.91 | 67.60 | 1168 |
| HSA-MIR-3928-5P | 98.50 | 67.48 | 980 |
| HSA-MIR-6806-3P | 98.50 | 67.31 | 980 |
| HSA-MIR-581 | 98.39 | 67.42 | 835 |
| HSA-MIR-3179 | 98.22 | 65.90 | 1445 |
| HSA-MIR-3130-5P | 98.14 | 66.00 | 711 |
| HSA-MIR-193B-5P | 97.91 | 65.88 | 837 |
| HSA-MIR-127-5P | 97.78 | 67.64 | 869 |
| HSA-MIR-4482-5P | 97.53 | 65.68 | 598 |
| HSA-MIR-6855-5P | 97.51 | 66.03 | 830 |
| HSA-MIR-3118 | 97.11 | 66.58 | 984 |
| HSA-MIR-134-5P | 97.11 | 66.52 | 976 |
Functional genomics
gnomAD constraint: pLI 1.88e-26, LOEUF 1.34, missense Z 0.361 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000447353 — one region, missense o/e 0.95.
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cfap210 | ENSMUSG00000070883 |
| rattus_norvegicus | Cfap210 | ENSRNOG00000052954 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | E1BJL9 | 84.8% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| PHOSPHO2-KLHL23 | protein-coding | 100526832 |
| PHOSPHO2 | protein-coding | 493911 |
| FASTKD1 | protein-coding | 79675 |
| PPIG | protein-coding | 9360 |
| KLHL23 | protein-coding | 151230 |
| KLHL41 | protein-coding | 10324 |
| BBS5 | protein-coding | 129880 |
Protein
Protein identifiers
Cilia- and flagella- associated protein 210 — Q0VFZ6 (reviewed: Q0VFZ6)
Alternative names: Coiled-coil domain-containing protein 173
All UniProt accessions (4): Q0VFZ6, B4DX81, C9J9F8, C9JQ25
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme. Flagellum axoneme.
Tissue specificity. Expressed in airway epithelial cells.
RefSeq proteins (1): NP_001078916* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039986 | CFAP210 | Family |
| IPR043597 | TPH_dom | Domain |
Pfam: PF13868
UniProt features (7 total): coiled-coil region 4, chain 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
2 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 7UNG | 48-nm repeat of the human respiratory doublet microtubule | ELECTRON MICROSCOPY | 3.6 |
| 8J07 | 96nm repeat of human respiratory doublet microtubule and associated axonemal complexes | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q0VFZ6-F1 | 81.20 | 0.38 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Antibody reliability (HPA): IH approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 75 (showing top):
SHEPARD_BMYB_MORPHOLINO_UP, FOSTER_TOLERANT_MACROPHAGE_DN, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOCC_CYTOPLASMIC_REGION, GOCC_MOTILE_CILIUM, GOCC_CYTOPLASMIC_MICROTUBULE, GOCC_CILIUM, DODD_NASOPHARYNGEAL_CARCINOMA_DN, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D, GOCC_AXONEMAL_MICROTUBULE, GOCC_9PLUS2_MOTILE_CILIUM, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER
GO Biological Process (1): flagellated sperm motility (GO:0030317)
GO Cellular Component (6): axonemal microtubule (GO:0005879), axoneme (GO:0005930), sperm flagellum (GO:0036126), axonemal B tubule inner sheath (GO:0160112), cilium (GO:0005929), polymeric cytoskeletal fiber (GO:0099513)
GO top-level categories
16 GO namespaces:
| Category | Terms |
|---|---|
| cytoskeleton | 2 |
| cellular anatomical structure | 2 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| cytoplasmic microtubule | 1 |
| axoneme | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| 9+2 motile cilium | 1 |
| A axonemal microtubule | 1 |
| axonemal microtubule doublet inner sheath | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| supramolecular fiber | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 2 of 7 annotations. The rest are phylogenetic / computational / electronic (IEA).
2 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| axonemal microtubule | CC | direct assay |
| axoneme | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 895 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP210 | CCDC190 | Q86UF4 | 543 |
| CFAP210 | CCDC160 | A6NGH7 | 526 |
| CFAP210 | CCDC60 | Q8IWA6 | 489 |
| CFAP210 | CFAP77 | Q6ZQR2 | 470 |
| CFAP210 | CCDC13 | Q8IYE1 | 457 |
| CFAP210 | CCDC17 | Q96LX7 | 443 |
| CFAP210 | PHOSPHO2 | Q8TCD6 | 435 |
| CFAP210 | ODR4 | Q5SWX8 | 419 |
| CFAP210 | ZNF169 | Q14929 | 419 |
| CFAP210 | SPACA9 | Q96E40 | 408 |
| CFAP210 | CCDC68 | Q9H2F9 | 391 |
| CFAP210 | AK9 | Q5TCS8 | 388 |
| CFAP210 | KLHL23 | Q8NBE8 | 386 |
| CFAP210 | DRC2 | Q8IXS2 | 368 |
| CFAP210 | ERICH3 | Q5RHP9 | 357 |
IntAct
Human interaction partners of CFAP210 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
1 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| DUSP14 | association | 0.530 | 2 |
Disease & clinical
Genetic variants
Variant evidence for CFAP210: 80 ClinVar records (1 pathogenic / likely pathogenic). Per-variant detail is on Sugi Variant.
ClinVar
80 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 74 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
Showing all 1 pathogenic / likely-pathogenic ClinVar records, ranked by ClinVar review status (expert panel → multiple submitters → single submitter), then by number of submitting labs.
| Variant ID | HGVS | Classification | Review | Submitters |
|---|---|---|---|---|
| 60248 | GRCh38/hg38 2q24.3-32.1(chr2:163965382-182195062)x1 | Pathogenic | criteria provided, single submitter | 1 |
Per-variant reference — Sugi Variant
Explore CFAP210’s pathogenic and likely-pathogenic variants individually — each with its ClinVar classification and conditions, applied ACMG criteria (ClinGen expert panel, where curated), the calibrated in-silico predictors (AlphaMissense, REVEL, SaProt, conservation), gnomAD frequency, and the predictor-disagreement QC signal — on Sugi Variant.
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 27 predictions of 885):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 2:169649180–169649181 | donor_loss | 1.0000 | 5 |
| 2:169649348 | acceptor_loss | 1.0000 | |
| 2:169649351–169649355 | acceptor_gain | 1.0000 | 4 |
| 2:169654216 | acceptor_gain | 1.0000 | |
| 2:169674859 | donor_gain | 1.0000 | |
| 2:169674886 | donor_gain | 1.0000 | |
| 2:169674939 | donor_gain | 1.0000 | |
| 2:169675041–169675042 | acceptor_loss | 1.0000 | 6 |
| 2:169694269 | donor_gain | 1.0000 | |
| 2:169646183–169646184 | acceptor_loss | 0.9900 | 6 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Uterine Corpus Endometrial Carcinoma)
Disease associations
OMIM: gene `` | disease phenotypes:
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol S | decreases expression, increases methylation | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| trichostatin A | affects expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, affects response to substance, increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Clozapine | affects cotreatment, increases expression | 1 |
| Cuprizone | affects cotreatment, increases expression | 1 |
| Folic Acid | increases expression | 1 |
| Lipopolysaccharides | increases expression, affects cotreatment, affects response to substance | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.